Form 4: Redmile Group Acquires Stock Options in Shattuck Labs, Inc.

Sentiment:

SEC Form 4


Redmile Group, through managing director Michael Lee's board service, acquires stock options in Shattuck Labs, Inc., with Jeremy Green also potentially deemed a beneficial owner.

Summary

  • Redmile Group, LLC acquired stock options in Shattuck Labs, Inc. on June 21, 2024.
  • The options are for 27,700 shares of common stock at an exercise price of $4.37.
  • The options vest on the earlier of one year from the grant date or immediately before the next annual meeting, contingent on Michael Lee's continued service.
  • Michael Lee, a managing director of Redmile, holds the options as a nominee for Redmile's benefit and has assigned all rights to Redmile.
  • Jeremy Green, as principal of Redmile, may also be deemed a beneficial owner of the options.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard SEC filing indicating a transaction. The disclaimers of beneficial ownership add a layer of complexity but don't necessarily indicate positive or negative sentiment.

Management Comments

  • Mr. Lee disclaims beneficial ownership of the stock option.
  • Redmile and Mr. Green disclaim beneficial ownership of the stock option except to the extent of their pecuniary interest therein.

Industry Context

This filing reflects ongoing investment activity in the biotech sector, with Redmile Group making strategic acquisitions in Shattuck Labs, Inc.

Key Dates

DateDescription
06/21/2024Date of transaction: Redmile Group acquired stock options.
06/21/2024Date of signature for the Form 4 filing.
06/21/2034Expiration date of the stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.